Dorzagliatin is primarily used in the treatment of type 2 diabetes mellitus. It functions as a glucokinase activator, targeting the enzyme glucokinase which plays a crucial role in glucose metabolism. By activating this enzyme, it helps to regulate blood sugar levels more effectively, particularly by enhancing the body's ability to manage glucose in both the liver and pancreas. This dual action aids in improving insulin secretion and reducing excessive glucose production by the liver, which are common issues in type 2 diabetes. The use of this chemical can lead to better glycemic control, reducing the risk of diabetes-related complications. It is often considered for patients who have not achieved adequate blood sugar control with other diabetes medications, offering a novel approach to managing this chronic condition.